ASX:EXL

Elixinol Wellness Stock Forecast, Price & News

Add
Compare
Today's Range N/A
50-Day Range N/A
52-Week Range N/A
VolumeN/A
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Receive EXL News and Ratings via Email

Sign-up to receive the latest news and ratings for Elixinol Wellness and its competitors with MarketBeat's FREE daily newsletter.


About Elixinol Wellness

Elixinol Wellness Limited, through its subsidiaries, manufactures and distributes industrial hemp-based nutraceutical, dietary supplements, and skincare products in the Americas, Europe, and Australia. It distributes hemp-derived cannabidiol products under the Elixinol brand. The company was formerly known as Elixinol Global Limited and changed its name to Elixinol Wellness Limited in May 2021. The company was incorporated in 2017 and is headquartered in Sydney, Australia.

Headlines

See More Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous


MarketRank

Overall MarketRank

0.00 out of 5 stars

Analyst Opinion: 0.0Community Rank: 0.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles











Elixinol Wellness (ASX:EXL) Frequently Asked Questions

What stocks does MarketBeat like better than Elixinol Wellness?

Wall Street analysts have given Elixinol Wellness a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Elixinol Wellness wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

When is Elixinol Wellness' next earnings date?

Elixinol Wellness is scheduled to release its next quarterly earnings announcement on Monday, August 30th 2021.
View our earnings forecast for Elixinol Wellness
.

Who are Elixinol Wellness' key executives?

Elixinol Wellness' management team includes the following people:
  • Mr. Oliver Horn B.Sc., Global CEO & Exec. Director (Age 49, Pay $395.66k)
  • Mr. Ron Dufficy BEC, FCPA, Global Chief Financial Officer
  • Glen Zurcher, Account Director of Investor Relations Department
  • Ms. Teresa Cleary, Gen. Counsel & Company Sec.
  • Mr. Rob Hasselman, Pres of Americas
  • Ms. Beata Silber, Global Head of R&D and Innovation
  • Ms. Kim Bradley-Ware, Joint Company Sec.

Who are some of Elixinol Wellness' key competitors?

What is Elixinol Wellness' stock symbol?

Elixinol Wellness trades on the ASX under the ticker symbol "EXL."

How much money does Elixinol Wellness make?

Elixinol Wellness has a market capitalization of $0.00 and generates $15.01 million in revenue each year.

What is Elixinol Wellness' official website?

The official website for Elixinol Wellness is www.elixinolglobal.com.

How can I contact Elixinol Wellness?

The company can be reached via phone at 61 2 4044 4585.


This page was last updated on 7/30/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.